ArticleInternational journal of cancer2013

Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle delivery.

Xinping Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.